September 6, 2018 10:09 AM EDT
News Briefing

Ar­row­head touts hep B da­ta, shares rock­et up; Eli Lil­ly's an­i­mal health unit files big IPO

John Carroll

Editor & Founder

→ Ar­row­head Phar­ma­ceu­ti­cals saw its share price $AR­WR rock­et up 43% on Thurs­day morn­ing af­ter the com­pa­ny un­veiled new da­ta that it says sup­port the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times